C. Miller Fisher
Charles Miller Fisher (December 5, 1913 – April 14, 2012) was a Canadian-American neurologist renowned for his pioneering research in the field of stroke and cerebrovascular disease. His work significantly advanced the understanding of the mechanisms, diagnosis, and treatment of stroke, and he is often referred to as the "father of modern stroke research."
Early Life and Education[edit | edit source]
C. Miller Fisher was born in Waterloo, Ontario, Canada. He completed his undergraduate studies at the University of Toronto and went on to earn his medical degree from the same institution in 1938. Following his graduation, Fisher served as a medical officer in the Royal Canadian Navy during World War II.
Career[edit | edit source]
After the war, Fisher pursued further training in neurology at the Montreal Neurological Institute under the mentorship of Wilder Penfield. He later moved to the United States to continue his research and clinical work. Fisher joined the faculty at Harvard Medical School and worked at the Massachusetts General Hospital, where he conducted much of his groundbreaking research.
Contributions to Neurology[edit | edit source]
Fisher's research focused on the pathology and clinical aspects of stroke. He was instrumental in identifying the role of atherosclerosis in cerebrovascular disease and described several important clinical syndromes, including:
- Lacunar stroke: Fisher's work on small vessel disease in the brain led to the identification of lacunar strokes, which are caused by the occlusion of small penetrating arteries.
- Transient ischemic attack (TIA): Fisher was one of the first to describe TIAs as "mini-strokes" that serve as warning signs for future strokes.
- Fisher syndrome: A variant of Guillain-Barré syndrome, characterized by ataxia, areflexia, and ophthalmoplegia.
Legacy[edit | edit source]
C. Miller Fisher's contributions to neurology have had a lasting impact on the field. His work laid the foundation for modern stroke prevention and treatment strategies. Fisher received numerous awards and honors throughout his career, including the American Heart Association's Gold Heart Award.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD